Glucerna

a specialized formula with low-carbohydrate, high-monounsaturated-fat content that has been enriched with a fiber source that permits tube feeding, has been shown to improve glycemic control and decrease the potential for complications

Also Known As:

Networked: 10 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Bleumink, Gysele: 1 article (11/2014)
2.	Botros, Nadia: 1 article (11/2014)
3.	Brandts, Hans: 1 article (11/2014)
4.	Janssen, Ignace: 1 article (11/2014)
5.	Rijnaarts, Iris: 1 article (11/2014)
6.	de Boer, Hans: 1 article (11/2014)
7.	Bisschop, Peter H: 1 article (08/2014)
8.	Endert, Erik: 1 article (08/2014)
9.	Fliers, Eric: 1 article (08/2014)
10.	Jurgens, Jordy: 1 article (08/2014)

Related Diseases

1.	Diabetes Mellitus 01/01/2013 - "In studies, Glucerna helped decrease the body weight and waist circumference in obesity and diabetes mellitus." 01/01/2009 - "To compare the effect of 2 liquid nutritional supplements (Enterex Diabetic and Glucerna SR) designed for the patient with diabetes mellitus on postprandial glucose, insulin secretion, and insulin sensitivity in healthy individuals. " 05/01/2006 - "To identify the effect of a nutritional liquid supplement designed for the patient with diabetes mellitus (Glucerna SR) in single administration on the postprandial glucose state, insulin secretion and insulin sensitivity in healthy subjects. " 05/01/2006 - "Effect of a nutritional liquid supplement designed for the patient with diabetes mellitus (Glucerna SR) on the postprandial glucose state, insulin secretion and insulin sensitivity in healthy subjects."
2.	Obesity 01/01/2013 - "In studies, Glucerna helped decrease the body weight and waist circumference in obesity and diabetes mellitus."
3.	Body Weight (Weight, Body) 01/01/2013 - "In studies, Glucerna helped decrease the body weight and waist circumference in obesity and diabetes mellitus."
4.	Type 2 Diabetes Mellitus (MODY) 08/28/2014 - "In the present randomised, controlled, cross-over design, twenty patients with type 2 diabetes consumed either a breakfast replacement consisting of an isoenergetic amount of Glucerna SR or a free-choice breakfast for 3 months. " 02/01/2008 - "Open-label, randomized, multiple-center, parallel study comparing glycemic responses and safety profiles of Glucerna versus Fresubin in subjects of type 2 diabetes mellitus." 11/01/1998 - "Thirty-two individuals with NIDDM were randomized to receive either Ensure with Fibre (30% fat) or a high monounsaturated fatty acid product, Glucerna (50% fat). " 01/01/2005 - "This trial included type 2 diabetes patients admitted to the hospital for neurologic disorders or head and neck cancer surgery who received either a low-carbohydrate-high-mono-unsaturated-fat (Glucerna) or a high-carbohydrate diet (Precitene Diabet). "
5.	Weight Loss (Weight Reduction) 09/01/2010 - "The study examined Glucerna Weight Loss Shake, Slim-Fast Shake, and Ensure with Fiber Shake, using a prospective, 3-way, cross-over design. "

Related Drugs and Biologics

1.	Unsaturated Fats
2.	Carbohydrates
3.	Fresubin
4.	Glucose (Dextrose)
5.	Glucerna
6.	Insulin (Novolin)
7.	Monounsaturated Fatty Acids
8.	2-methylcyclopentadienyl manganese tricarbonyl (MMT)